Literature DB >> 8094715

Molecular and cellular heterogeneity of Wilms' tumor.

S Velasco1, D D'Amico, N R Schneider, C Timmons, E Chappell, D Lee, P D Nisen.   

Abstract

We developed a Wilms' tumor-cell culture system to investigate the molecular basis of nephrogenesis and oncogenesis. Several distinct fractions of cells were isolated and characterized from the same tumor specimen. The cells exhibited striking differences in morphology, immunocytochemical staining profiles and cytogenetics. One fraction contained cells with features of epithelium; other cell fractions resembled partially differentiated mesenchyme (blastema or stroma). While the Wilms' tumor-suppressor gene WT1 was not altered, loss of heterozygosity (LOH) and an insertion in intron I of the p53 tumor-suppressor gene occurred in the tumor and the cultured cell types. LOH for RB was detected only in the cultured cells. These findings are consistent with a model of tumor initiation in a pluripotent cell that is able to undergo subsequent differentiation along multiple different lines and which mimics normal nephrogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094715     DOI: 10.1002/ijc.2910530425

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

2.  p53 protein expression in nephroblastomas: a predictor of poor prognosis.

Authors:  D Govender; P Harilal; G P Hadley; R Chetty
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.

Authors:  Lourdes Hontecillas-Prieto; Daniel J García-Domínguez; Rosa García-Mejías; Gema L Ramírez-Villar; Carmen Sáez; Enrique de Álava
Journal:  Oncotarget       Date:  2017-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.